The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
VEGF Gene Delivery to Myocardium: Deleterious Effects of Unregulated Expression
Abstract
Background —Vascular endothelial growth factor (VEGF) is being investigated for therapeutic angiogenesis in ischemic myocardium. Primarily, transient delivery systems have been tested. The goal of this study was to investigate the effects of continuous expression of VEGF in myocardium by use of myoblast-mediated delivery. Methods and Results —Primary murine myoblasts (5×10 5 cells in 10 μL of PBS with 0.5% BSA) expressing both the murine VEGF gene and the β-galactosidase (β-gal) gene from a retroviral promoter were implanted in the ventricular wall of immunodeficient mice (n=11) via a subdiaphragmatic approach. Control immunodeficient mice (n=12) were injected with the same number of myoblasts expressing only the β-gal gene. Between days 14 and 16, surviving mice were euthanized and the hearts processed for histology. In the experimental group, 11 of 11 mice demonstrated failure to thrive by day 13; 5 deaths occurred between days 8 and 15. There were no complications in the control mice. Histochemistry documented successful implantation of myoblasts (positive β-gal reaction product) in 6 of 6 surviving experimental mice and 12 of 12 controls. Histology disclosed intramural vascular tumors resembling hemangiomas in the VEGF-myoblast–injected myocardium in 6 of 6 surviving mice. β-Gal–expressing cells were present at the site of the vascular tumors. Immunohistochemistry localized abundant endothelial nitric oxide synthase and CD31 (platelet and endothelial cell adhesion molecule) within the lesion, consistent with the presence of endothelial cells. Conclusions —In this model, unregulated continuous expression of VEGF is associated with (1) a high rate of failure to thrive/death and (2) formation of endothelial cell–derived intramural vascular tumors in the implantation site. These results underscore the importance of regulating VEGF expression for therapeutic angiogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isner, J. M., Pieczek, A., Schainfeld, R., Blair, R., Haley, L., Asahara, T., Rosenfield, K., Razvi, S., Walsh, K., & Symes, J. F. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03361-2 · Cited by 989
Losordo, D. W., Vale, P. R., Symes, J. F., Dunnington, C. H., Esakof, D. D., Maysky, M., Ashare, A. B., Lathi, K., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.98.25.2800 · Cited by 987
Rando, T. A., & Blau, H. M. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.6.1275 · Cited by 936
Self-citationRosengart, T. K., Lee, L. Y., Patel, S. R., Sanborn, T. A., Parikh, M., Bergman, G. W., Hachamovitch, R., Szulc, M., Kligfield, P. D., Okin, P. M., et al. (1999) · Circulation · doi:10.1161/01.cir.100.5.468 · Cited by 656
Skeletal myoblast transplantation for repair of myocardial necrosis.
Murry, C. E., Wiseman, R. W., Schwartz, S. M., & Hauschka, S. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119070 · Cited by 615
Banai, S., Jaklitsch, M. T., Shou, M., Lazarous, D. F., Scheinowitz, M., Biro, S., Epstein, S. E., & Unger, E. F. (1994) · Circulation · doi:10.1161/01.cir.89.5.2183 · Cited by 596
Reinecke, H., Zhang, M., Bartosek, T., & Murry, C. E. (1999) · Circulation · doi:10.1161/01.cir.100.2.193 · Cited by 515
Tsurumi, Y., Takeshita, S., Chen, D., Kearney, M., Rossow, S. T., Passeri, J., Horowitz, J. R., Symes, J. F., & Isner, J. M. (1996) · Circulation · doi:10.1161/01.cir.94.12.3281 · Cited by 389
Springer, M. L., Chen, A. S., Kraft, P. E., Bednarski, M., & Blau, H. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80154-9 · Cited by 363
Self-citationTremblay, J. P., Malouin, F., Roy, R., Huard, J., Bouchard, J. P., Satoh, A., & Richards, C. L. (1993) · Cell Transplantation · doi:10.1177/096368979300200203 · Cited by 345
The fate of individual myoblasts after transplantation into muscles of DMD patients
Gussoni, E., Blau, H. M., & Kunkel, L. M. (1997) · Nature Medicine · doi:10.1038/nm0997-970 · Cited by 330
Self-citationMagnetic resonance mapping demonstrates benefits of VEGF–induced myocardial angiogenesis
Pearlman, J. D., Hibberd, M. G., Chuang, M. L., Harada, K., Lopez, J. J., Gladstone, S. R., Friedman, M., Sellke, F. W., & Simons, M. (1995) · Nature Medicine · doi:10.1038/nm1095-1085 · Cited by 326
Systemic Delivery of Human Growth Hormone by Injection of Genetically Engineered Myoblasts
Dhawan, J., Pan, L. C., Pavlath, G. K., Travis, M. A., Lanctot, A. M., & Blau, H. M. (1991) · Science · doi:10.1126/science.1962213 · Cited by 317
Self-citationMack, C. A., Patel, S. R., Schwarz, E. A., Zanzonico, P., Hahn, R. T., Ilercil, A., Devereux, R. B., Goldsmith, S. J., Christian, T. F., Sanborn, T. A., et al. (1998) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(98)70455-6 · Cited by 305
Dai, Y., Roman, M., Naviaux, R. K., & Verma, I. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10892 · Cited by 302
Hendel, R. C., Henry, T. D., Rocha-Singh, K., Isner, J. M., Kereiakes, D. J., Giordano, F. J., Simons, M., & Bonow, R. O. (2000) · Circulation · doi:10.1161/01.cir.101.2.118 · Cited by 295
Systemic Delivery of Recombinant Proteins by Genetically Modified Myoblasts
Barr, E., & Leiden, J. M. (1991) · Science · doi:10.1126/science.1962212 · Cited by 281
Leor, J., Patterson, M., Quiñones, M. J., Kedes, L., & Kloner, R. A. (1996) · PubMed · Cited by 276
Flamme, I., von Reutern, M., Drexler, H. C. A., Syed-Ali, S., & Risau, W. (1995) · Developmental Biology · doi:10.1006/dbio.1995.1291 · Cited by 220
Takeshita, S., Tsurumi, Y., Couffinahl, T., Asahara, T., Bauters, C., Symes, J. F., Ferrara, N., & Isner, J. M. (1996) · PubMed · Cited by 211
Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette.
Hofmann, A., Nolan, G. P., & Blau, H. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5185 · Cited by 185
Self-citationRossi, F. M. V., Guicherit, O. M., Spicher, A., Kringstein, A. M., Fátyol, K., Blakely, B. T., & Blau, H. M. (1998) · Nature Genetics · doi:10.1038/3871 · Cited by 121
Self-citationTakeshita, S., Rossow, S., Kearney, M., Zheng, L. P., Bauters, C., Bunting, S., Ferrara, N., Symes, J. F., & Isner, J. M. (1995) · Europe PMC (PubMed Central) · Cited by 108
Tet B or not tet B: Advances in tetracycline-inducible gene expression
Blau, H. M., & Rossi, F. M. V. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.3.797 · Cited by 107
Self-citationGraded transcriptional response to different concentrations of a single transactivator
Kringstein, A. M., Rossi, F. M. V., Hofmann, A., & Blau, H. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13670 · Cited by 103
Self-citationPatel, S. R., Lee, L. Y., Mack, C. A., Polce, D. R., El-Sawy, T., Hackett, N. R., Ilercil, A., Jones, E. C., Hahn, R. T., Isom, O. W., et al. (1999) · Human Gene Therapy · doi:10.1089/10430349950018012 · Cited by 55
Human gene therapy with myoblast transfer
Law (1996) · Cell Transplantation · doi:10.1016/0963-6897(96)82326-8 · Cited by 5
Cited by
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
The FGF family: biology, pathophysiology and therapy
Beenken, A., & Mohammadi, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2792 · Cited by 1,945
Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration
Rafii, S., & Lyden, D. (2003) · Nature Medicine · doi:10.1038/nm0603-702 · Cited by 1,577
Vascularization in tissue engineering
Rouwkema, J., Rivron, N. C., & van Blitterswijk, C. A. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.04.009 · Cited by 1,211
Metadata
- Authors
- Lee, R. J., Springer, M. L., Blanco-Bose, W. E., Shaw, R., Ursell, P. C., & Blau, H. M.
- Venue
- Circulation
- Published
- 2000-08-22
- Volume
- 102
- Issue
- 8
- Pages
- 898-901
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2119841264
- Cited by
- 697
- References
- 27
- FWCI
- 14.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.